FCGR3A and neoplasm: Several studies have demonstrated that CD16-triggered ADCC and phagocytosis, mediated by NK cells and monocyte/macrophages, respectively, are the principal immune-dependent mechanisms through which tumor-targeting mAbs may mediate tumor cell killing and attain therapeutic efficacy [78].